Oligosaccharidoses and Sialic Acid Disorders

  • Zoltan LukacsEmail author
  • Michael Beck


Oligosaccharidosis comprises a group of disorders which show glycoprotein excretion in urine and diminished activity of lysosomal enzymes that are involved in the degradation of sugar side chains. Among those are glycosylasparaginase deficiency (aspartylglucosaminuria), α-l-fucosidase deficiency (fucosidosis), α- and β-mannosidase deficiency (α- and β-mannosidosis), α-N-acetylgalactosaminidase deficiency (Schindler and Kanzaki disease), and neuraminidase deficiency (sialidosis). In contrast to the latter, where degradation of sialic acid containing glycosides is impaired, Salla disease results from a defect in sialin, a membrane transporter protein. Consequently, sialic acid is stored in the lysosomes. The diseases are rare and present a wide phenotypic spectrum. Detection of oligosaccharides in urine and enzyme activity measurements in leukocytes or fibroblasts is usually diagnostic. Free sialic acid has to be assessed by HPLC. For final confirmation, a molecular genetic test should be carried out. To date mainly palliative therapies can be provided.


Hematopoietic Stem Cell Transplantation Sialic Acid Enzyme Replacement Therapy Lysosomal Storage Disorder Lysosomal Storage Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Alkhayat AH, Kraemer SA, Leipprandt JR, Macek M, Kleijer WJ, Friderici KH (1998) Human beta-mannosidase cDNA characterization and first identification of a mutation associated with human beta-mannosidosis. Hum Mol Genet 7:75–83PubMedCrossRefGoogle Scholar
  2. Aronson NN (1999) Aspartylglycosaminuria: biochemistry and molecular biology. Biochim Biophys Acta 1455:139–154PubMedCrossRefGoogle Scholar
  3. Arvio M, Oksanen V, Autio S et al (1993) Epileptic seizures in aspartylglucosaminuria: a common disorder. Acta Neurol Scand 87:342–344PubMedCrossRefGoogle Scholar
  4. Arvio M, Sauna-Aho O, Peippo M (2001) Bone marrow transplantation for aspartylglucosaminuria: follow-up study of transplanted and non-transplanted patients. J Pediatr 138:288–290PubMedCrossRefGoogle Scholar
  5. Aula P, Autio S, Raivio K, Näntö V (1974) Detection of heterozygotes for aspartylglucosaminuria (AGU) in cultured fibroblasts. Humangenetik 25:307–314PubMedCrossRefGoogle Scholar
  6. Aula P, Raivio K, Autio S (1976) Enzymatic diagnosis and carrier detection of aspartylglucosaminuria using blood samples. Pediatr Res 10:625–629PubMedCrossRefGoogle Scholar
  7. Aula P, Autio S, Raivio KO, Rapola J, Thoden C-J, Koskela S-L, Yamashina I (1979) “Salla disease”: a new lysosomal storage disorder. Arch Neurol 36:88–94PubMedCrossRefGoogle Scholar
  8. Bakker HD, de Sonnaville ML, Vreken P, Abeling NG, Groener JE, Keulemans JL, van Diggelen OP (2001) Human alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency: no association with neuroaxonal dystrophy. Eur J Hum Genet 9:91–96PubMedCrossRefGoogle Scholar
  9. Bedilu R, Nummy KA, Cooper A, Wevers R, Smeitink J, Kleijer WJ, Friderici KH (2002) Variable clinical presentation of lysosomal beta-mannosidosis in patients with null mutations. Mol Genet Metab 77:282–290PubMedCrossRefGoogle Scholar
  10. Berg T, Riise HM, Hansen GM, Malm D, Tranebjaerg L, Tollersrud OK, Nilssen O (1999) Spectrum of mutations in alpha-mannosidosis. Am J Hum Genet 64:77–88PubMedCentralPubMedCrossRefGoogle Scholar
  11. Cooper A, Hatton C, Sardharwalla IB (1987) Acid beta-mannosidase of human plasma: influence of age and sex on enzyme activity. J Inherit Metab Dis 10:229–233PubMedCrossRefGoogle Scholar
  12. Cooper A, Hatton C, Thornley M, Sardharwalla IB (1988) Human beta-mannosidase deficiency: biochemical findings in plasma, fibroblasts, white cells and urine. J Inherit Metab Dis 11:17–29PubMedCrossRefGoogle Scholar
  13. Cooper A, Hatton CE, Thornley M, Sardharwalla IB (1990) alpha- and beta-mannosidosis. J Inherit Metab Dis 13:538–548PubMedCrossRefGoogle Scholar
  14. Damme M, Stroobants S, Walkley SU et al (2011) Cerebellar alterations and gait defects as therapeutic outcome measures for enzyme replacement therapy in alpha-mannosidosis. J Neuropathol Exp Neurol 70:83–94PubMedCentralPubMedCrossRefGoogle Scholar
  15. Dunder U, Valtonen P, Kelo E et al (2010) Early initiation of enzyme replacement therapy improves metabolic correction in the brain tissue of aspartylglycosaminuria mice. J Inherit Metab Dis 33:611–617PubMedCrossRefGoogle Scholar
  16. Erikson A, Aula N, Aula P (2002) Free sialic acid storage (Salla) disease in Sweden. Acta Paediatr 91:1324–1327PubMedCrossRefGoogle Scholar
  17. Gordon BA, Gordon KE, Seo HC et al (1995) Fucosidosis with dystonia. Neuropediatrics 26:325–327PubMedCrossRefGoogle Scholar
  18. Kanzaki T, Wang AM, Desnick RJ (1991) Lysosomal alpha-N-acetylgalactosaminidase deficiency, the enzymatic defect in angiokeratoma corporis diffusum with glycopeptiduria. J Clin Invest 88:707–711PubMedCentralPubMedCrossRefGoogle Scholar
  19. Keulemans JL, Reuser AJ, Kroos MA, Willemsen R, Hermans MM, van den Ouweland AM, de Jong JG et al (1996) Human alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency: new mutations and the paradox between genotype and phenotype. J Med Genet 33:458–464PubMedCentralPubMedCrossRefGoogle Scholar
  20. Krivit W (2004) Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases. Springer Semin Immunopathol 26:119–132PubMedCrossRefGoogle Scholar
  21. Malatack JJ, Consolini DM, Bayever E (2003) The status of hematopoietic stem cell transplantation in lysosomal storage disease. Pediatr Neurol 29:391–403PubMedCrossRefGoogle Scholar
  22. Malm D, Nilssen Ø (2008) Alpha-mannosidosis. Orphanet J Rare Dis 3:21. doi: 10.1186/1750-1172-3-21 PubMedCentralPubMedCrossRefGoogle Scholar
  23. Malm G, Mansson JE, Winiarski J et al (2004) Five-year follow-up of two siblings with aspartylglucosaminuria undergoing allogeneic stem-cell transplantation from unrelated donors. Transplantation 78:415–419PubMedCrossRefGoogle Scholar
  24. Mononen I, Mononen T, Ylikangas P, Kaartinen V, Savolainen K (1994) Enzymatic diagnosis of aspartylglycosaminuria by fluorometric assay of glycosylasparaginase in serum, plasma, or lymphocytes. Clin Chem 40:385–388PubMedGoogle Scholar
  25. Mueller O, Henry W, Haley L (1986) Sialidosis and galactosialidosis: chromosomal assignment of two genes associated with neuraminidase-deficiency disorders. Proc Natl Acad Sci U S A 83:1817–1821PubMedCentralPubMedCrossRefGoogle Scholar
  26. Palo J, Mattsson K (1970) Eleven new cases of aspartylglucosaminuria. J Ment Defic Res 14:168–173PubMedGoogle Scholar
  27. Pollitt R, Jenner F (1968) Aspartylglucosaminuria: an inborn error of metabolism associated with mental defect. Lancet 2:253–255Google Scholar
  28. Saarela J, Laine M, Oinonen C, von Schantz C, Jalanko A, Rouvinen J, Peltonen L (2001) Molecular pathogenesis of a disease: structural consequences of aspartylglucosaminuria mutations. Hum Mol Gen 10:983–995PubMedCrossRefGoogle Scholar
  29. Sabourdy F, Labauge P, Stensland HMFR, Nieto M, Garcés VL, Renard D, Castelnovo G, de Champfleur N, Levade T (2009) A MANBA mutation resulting in residual beta-mannosidase activity associated with severe leukoencephalopathy: a possible pseudodeficiency variant. BMC Med Genet 10:84PubMedCentralPubMedCrossRefGoogle Scholar
  30. Saito S, Ohno K, Sugawara K, Suzuki T, Togawa T, Sakuraba H (2008) Structural basis of aspartylglucosaminuria. Biochem Biophys Res Commun 377:1168–1172PubMedCrossRefGoogle Scholar
  31. Sands MS, Davidson BL (2006) Gene therapy for lysosomal storage diseases. Mol Ther 13:839–849PubMedCrossRefGoogle Scholar
  32. Seyrantepe V, Poupetova H, Froissart R (2003) Molecular pathology of NEU1 gene in sialidosis. Hum Mutat 22:343–352PubMedCrossRefGoogle Scholar
  33. Soltani AE, Moharari RS, Ghaffari R et al (2007) Fucosidosis and anesthesia. Saudi Med J 28:1446–1448PubMedGoogle Scholar
  34. Stensland HMFR, Persichetti E, Sorriso C, Hansen GM, Bibi L, Paciotti S, Balducci C, Beccari T (2008) Identification of two novel β-mannosidosis-associated sequence variants: biochemical analysis of β-mannosidase (MANBA) missense mutations. Mol Genet Metab 94:476–480CrossRefGoogle Scholar
  35. van den Bosch J, Oemardien LF, Srebniak MI, Piraud M, Huijmans JGM, Verheijen FW, Ruijter GJG (2011) Prenatal screening of sialic acid storage disease and confirmation in cultured fibroblasts by LC-MS/MS. J Inherit Metab Dis. doi: 10.1007/s10545-011-9351-3 Google Scholar
  36. Verheijen FW, Verbeek E, Aula N, Beerens CEMT, Havelaar AC, Joosse M, Peltonen L et al (1999) A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases. Nat Genet 23:462–465PubMedCrossRefGoogle Scholar
  37. Virta S, Rapola J, Jalanko A et al (2006) Use of nonviral promoters in adenovirus-mediated gene therapy: reduction of lysosomal storage in the aspartylglucosaminuria mouse. J Gene Med 8:699–706PubMedCrossRefGoogle Scholar
  38. Vite CH, Mcgowan JC, Niogi SN et al (2005) Effective gene therapy for an inherited CNS disease in a large animal model. Ann Neurol 57:355–364PubMedCrossRefGoogle Scholar
  39. Westaway SK, Gregory A, Hayflick SJ (2007) Mutations in PLA2G6 and the riddle of Schindler disease. J Med Genet 44:e64PubMedCentralPubMedCrossRefGoogle Scholar
  40. Willems PJ, Seo HC, Coucke P, Tonlorenzi R, O’Brien JS (1999) Spectrum of mutations in fucosidosis. Eur J Hum Genet 7:60–67PubMedCrossRefGoogle Scholar
  41. Wong LT, Vallance H, Savage A et al (1993) Oral zinc therapy in the treatment of alpha-mannosidosis. Am J Med Genet 46:410–414PubMedCrossRefGoogle Scholar
  42. Zielke K, Veath M, O’Brian JS (1972) Fucosidosis: deficiency of alpha-L-fucosidase in cultured skin fibroblasts. J Exp Med 136:197–199PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Metabolic Laboratory, Department of Pediatrics University Medical CenterInstitute of Clinical ChemistryHamburgGermany
  2. 2.Villa MetabolicaUniversitäts-KinderklinikMainzGermany

Personalised recommendations